You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-FHL2 antibody (ab12327)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab12327? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab12327 has been referenced in 3 publications.

  1. Gökmen-Polar Y et al. Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer. Breast Cancer Res Treat 127:375-84 (2011). WB; Human. PubMed: 20602165
  2. Mille F et al. The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex. Nat Cell Biol 11:739-46 (2009). WB, ICC/IF; Human. PubMed: 19465923
  3. Hamidouche Z et al. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/{beta}-catenin signaling-dependent Runx2 expression. FASEB J : (2008). PubMed: 18653765

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"